49 for the third quarter of 2009.

Amgen’s Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent Amgen reported adjusted earnings per share of $1.49 for the third quarter of 2009, a rise of 21 % compared to $1 http://cialisinorge.com click here .23 for the third one fourth of 2008. Adjusted net income elevated 16 % to $1,518 million in the third quarter of 2009 compared to $1,308 million in the third quarter of 2008. Total income decreased 2 % during the third quarter of 2009 to $3,812 million versus $3,875 million in the 3rd one fourth of 2008. Our third quarter results reflect the continued stability of our primary businesses when confronted with increased competition, stated Kevin Sharer, chairman & ceo. We are delighted by the outcomes of clinical studies for denosumab and Vectibix that people recently provided at a scientific getting together with, and look forwards to producing these innovative medicines open to patients in their particular indications.

Other Posts From "gear":

Related Posts